HIV Citations List: February, 2017

Literature Citations

1. Human CaaX Protease ZMPSTE24 Expressed in Yeast: Structure and Inhibition by HIV Protease Inhibitors. Clark, K.M., J.L. Jenkins, N. Fedoriw, and M.E. Dumont. Protein Science, 2017. 26(2): p. 242-257. PMID[27774687]. PMCID[PMC5275749].
[PubMed]. HIV_02_2017.

2. Emtricitabine + Tenofovir Alafenamide for the Treatment of HIV. Corado, K.C. and E.S. Daar. Expert Opinion on Pharmacotherapy, 2017. 18(4): p. 427-432. PMID[28151023].
[PubMed]. HIV_02_2017.

3. Antiviral and Antitumor Activity of Licorice Root Extracts. Fukuchi, K., N. Okudaira, K. Adachi, R. Odai-Ide, S. Watanabe, H. Ohno, M. Yamamoto, T. Kanamoto, S. Terakubo, H. Nakashima, Y. Uesawa, H. Kagaya, and H. Sakagami. In Vivo, 2016. 30(6): p. 777-785. PMID[27815461].
[PubMed]. HIV_02_2017.

4. Synthesis of New Derivatives of 5-(3,4-Dihydro-2H-pyrrol-5-yl)-pyrimidine. Gasparyan, S.P., M.V. Alexanyan, G.K. Arutyunyan, S.L. Kocharov, A.H. Martirosyan, R.A. Tamazyan, A.G. Ayvazyan, H.A. Panosyan, and G.G. Danagulyan. Russian Journal of Organic Chemistry, 2016. 52(11): p. 1646-1653. ISI[000393045600016].
[WOS]. HIV_02_2017.

5. Tenofovir Alafenamide, Emtricitabine, Elvitegravir, and Cobicistat Combination Therapy for the Treatment of HIV. Imaz, A. and D. Podzamczer. Expert Review of Anti-Infective Therapy, 2017. 15(3): p. 195-209. PMID[28117606].
[PubMed]. HIV_02_2017.

6. Application of the Triazolization Reaction to Afford Dihydroartemisinin Derivatives with anti-HIV Activity. Jana, S., S. Iram, J. Thomas, M.Q. Hayat, C. Pannecouque, and W. Dehaen. Molecules, 2017. 22(E303): 13pp. PMID[28218680].
[PubMed]. HIV_02_2017.

7. Structural and Preclinical Studies of Computationally Designed Non-Nucleoside Reverse Transcriptase Inhibitors for Treating HIV Infection. Kudalkar, S.N., J. Beloor, A.H. Chan, W.G. Lee, W.L. Jorgensen, P. Kumar, and K.S. Anderson. Molecular Pharmacology, 2017. 91(4): p. 383-391. PMID[28167742].
[PubMed]. HIV_02_2017.

8. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile. Mao, T.Q., Q.Q. He, W.X. Chen, G.F. Tang, F.E. Chen, E. De Clercq, D. Daelemans, and C. Pannecouque. Current Pharmaceutical Design, 2016. 22(46): p. 6982-6987. ISI[000392864100012].
[WOS]. HIV_02_2017.

9. Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding. Martini, R., F. Esposito, A. Corona, R. Ferrarese, E.R. Ceresola, L. Visconti, C. Tintori, A. Barbieri, A. Calcaterra, V. Iovine, F. Canducci, E. Tramontano, and M. Botta. ChemBioChem, 2017. 18(4): p. 374-377. PMID[27992102].
[PubMed]. HIV_02_2017.

10. Anti-human Immunodeficiency Activity of Novel 2-Arylpyrrolidine Analogs. Martirosyan, A.H., S.P. Gasparyan, M.V. Alexanyan, G.K. Harutyunyan, H.A. Panosyan, and R.F. Schinazi. Medicinal Chemistry Research, 2017. 26(1): p. 101-108. ISI[000392064500010].
[WOS]. HIV_02_2017.

11. Isatin Thiazoline Hybrids as Dual Inhibitors of HIV-1 Reverse Transcriptase. Meleddu, R., S. Distinto, A. Corona, E. Tramontano, G. Bianco, C. Melis, F. Cottiglia, and E. Maccioni. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 32(1): p. 130-136. PMID[27766892].
[PubMed]. HIV_02_2017.

12. M48U1 and Tenofovir Combination Synergistically Inhibits HIV Infection in Activated PBMCs and Human Cervicovaginal Histocultures. Musumeci, G., I. Bon, D. Lembo, V. Cagno, M.C. Re, C. Signoretto, E. Diani, L. Lopalco, C. Pastori, L. Martin, G. Ponchel, D. Gibellini, and K. Bouchemal. Scientific Reports, 2017. 7(41018): 12pp. PMID[28145455]. PMCID[PMC5286506].
[PubMed]. HIV_02_2017.

13. Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-kappaB Pathways. Olmedo, D.A., J.L. Lopez-Perez, E. Del Olmo, L.M. Bedoya, R. Sancho, J. Alcami, E. Munoz, A.S. Feliciano, and M.P. Gupta. Molecules, 2017. 22(321): 13pp. PMID[28218730].
[PubMed]. HIV_02_2017.

14. SAMHD1 Enhances Nucleoside-analogue Efficacy against HIV-1 in Myeloid Cells. Ordonez, P., S. Kunzelmann, H.C. Groom, M.W. Yap, S. Weising, C. Meier, K.N. Bishop, I.A. Taylor, and J.P. Stoye. Scientific Reports, 2017. 7(42824): 14pp. PMID[28220857]. PMCID[PMC5318888].
[PubMed]. HIV_02_2017.

15. Anti-HIV Activities of Intramolecular G4 and Non-G4 Oligonucleotides. Prokofjeva, M., V. Tsvetkov, D. Basmanov, A. Varizhuk, M. Lagarkova, I. Smirnov, K. Prusakov, D. Klinov, V. Prassolov, G. Pozmogova, and S.N. Mikhailov. Nucleic Acid Therapeutics, 2017. 27(1): p. 56-66. PMID[27763826].
[PubMed]. HIV_02_2017.

16. Synthesis, Molecular Modeling and Biological Evaluation of Two New Chicoric acid Analogs. Righi, G., R. Pelagalli, V. Isoni, I. Tirotta, R. Dallocchio, A. Dessi, B. Macchi, C. Frezza, I. Rossetti, and P. Bovicelli. Natural Product Research, 2017. 31(4): p. 397-403. PMID[28010138].
[PubMed]. HIV_02_2017.

17. Tenofovir Alafenamide fumarate for the Treatment of HIV Infection. Sampath, R., J. Zeuli, S. Rizza, and Z. Temesgen. Drugs of Today, 2016. 52(11): p. 617-625. PMID[28112280].
[PubMed]. HIV_02_2017.

18. Synthesis and Antiviral Evaluation of 2',2',3',3'-Tetrafluoro nucleoside Analogs. Sari, O., L. Bassit, C. Gavegnano, T.R. McBrayer, L. McCormick, B. Cox, S.J. Coats, F. Amblard, and R.F. Schinazi. Tetrahedron Letters, 2017. 58(7): p. 642-644. PMID[28163339]. PMCID[PMC5289701].
[PubMed]. HIV_02_2017.

19. Au(III) Compounds as HIV Nucleocapsid Protein (NCp7)-Nucleic acid Antagonists. Spell, S.R., J.B. Mangrum, E.J. Peterson, D. Fabris, R. Ptak, and N.P. Farrell. Chemical Communications, 2017. 53(1): p. 91-94. PMID[27858001].
[PubMed]. HIV_02_2017.

20. Non-human Primate Schlafen11 Inhibits Production of Both Host and Viral Proteins. Stabell, A.C., J. Hawkins, M.Q. Li, X. Gao, M. David, W.H. Press, and S.L. Sawyer. Plos Pathogens, 2016. 12(12): e1006066. PMID[28027315]. PMCID[PMC5189954].
[PubMed]. HIV_02_2017.

21. Design, Synthesis and Biological Evaluation of (E)-3,4-Dihydroxystyryl-4-acylaminophenethyl sulfone, sulfoxide Derivatives as Dual Inhibitors of HIV-1 CCR5 and Integrase. Sun, Y., W. Xu, N. Fan, X. Sun, X. Ning, L. Ma, J. Liu, and X. Wang. Bioorganic & Medicinal Chemistry, 2017. 25(3): p. 1076-1084. PMID[28082070].
[PubMed]. HIV_02_2017.

22. Chiral Phosphoric acid Catalyzed Enantioselective Addition of Thiols to in Situ Generated Ketimines: Synthesis of N,S-Ketals. Unhale, R.A., N. Molleti, N.K. Rana, S. Dhanasekaran, S. Bhandary, and V.K. Singh. Tetrahedron Letters, 2017. 58(2): p. 145-151. ISI[000392038900008].
[WOS]. HIV_02_2017.

23. Discovery of Natural Mouse Serum Derived HIV-1 Entry Inhibitor(s). Wei, M., Y. Chen, J. Xi, S. Ru, M. Ji, D. Zhang, Q. Fang, and B. Tang. Acta Virologica, 2016. 60(4): p. 404-409. PMID[27928921].
[PubMed]. HIV_02_2017.

24. Nonnucleoside Reverse Transcriptase Inhibitors Reduce HIV-1 Production from Latently Infected Resting CD4+ T Cells Following Latency Reversal. Zerbato, J.M., G. Tachedjian, and N. Sluis-Cremer. Antimicrobial Agents and Chemotherapy, 2017. 61(3): e01736-16. PMID[27993846].
[PubMed]. HIV_02_2017.

25. Supramolecular Combinations of Humic Polyanions as Potent Microbicides with Polymodal anti-HIV-activities. Zhernov, Y.V., S. Kremb, M. Helfer, M. Schindler, M. Harir, C. Mueller, N. Hertkorn, N.P. Avvakumova, A.I. Konstantinov, R. Brack-Werner, P. Schmitt-Kopplin, and I.V. Perminova. New Journal of Chemistry, 2017. 41(1): p. 212-224. ISI[000391451500024].
[WOS]. HIV_02_2017.

Patent Citations

26. Preparation of Novel Substituted Betulinic amide Derivatives as HIV Inhibitors. Bandi, P.R., R.R. Kura, P.R. Adulla, D.K. Gazula Levi, V. Mukkera, S. Neela, and S.V.L. Lanka. Patent. 2017. 2016-IB54505 2017017630: 170pp.

[Patent]. HIV_02_2017.

27. Preparation of Triterpene-amide Compounds as HIV Inhibitors. Bandi, P.R., R.R. Kura, D.K. Gazula Levi, P.R. Adulla, S. Neela, and N. Mogili. Patent. 2017. 2016-IB54711 2017021922: 87pp.

[Patent]. HIV_02_2017.

28. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Eastman, K.J., J.F. Kadow, B.N. Naidu, K.E. Parcella, M. Patel, P. Sivaprakasam, and Y. Tu. Patent. 2017. 2016-IB54830 2017025915: 275pp.

[Patent]. HIV_02_2017.

29. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Eastman, K.J., J.F. Kadow, B.N. Naidu, K.E. Parcella, M. Patel, and Y. Tu. Patent. 2017. 2016-IB54089 2017006280: 85pp.

[Patent]. HIV_02_2017.

30. Preparation of Betulin Derivatives for Preventing or Treating HIV Infections. Johns, B.A. Patent. 2017. 2016-IB54458 2017017609: 105pp.

[Patent]. HIV_02_2017.

31. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Kadow, J.F., B.N. Naidu, M. Patel, J.L. Romine, D.R. St. Laurent, T. Wang, and Z. Zhang. Patent. 2017. 2016-IB54090 2017006281: 171pp.

[Patent]. HIV_02_2017.

32. Preparation of Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication. Kadow, J.F., B.N. Naidu, J.L. Romine, P. Sivaprakasam, and D.R. St. Laurent. Patent. 2017. 2016-IB54688 2017025864: 204pp.

[Patent]. HIV_02_2017.

33. Methods for Inhibiting HIV-1 Activity by Inhibitory Mechanisms of Extracts of Guaiacum officinale L. (Zygophyllaceae). Lowe, H., N.J. Toyang, and J. Bryant. Patent. 2017. 2015-14805324 20170020940: 10pp.

[Patent]. HIV_02_2017.

34. Preparation of Acyclic Nucleotide Β-amino acid ester phosphodiamides as Antiviral Agents. Vachal, P., I. Raheem, Z. Guo, and T.J. Hartingh. Patent. 2017. 2016-US45946 2017027434: 76pp.

[Patent]. HIV_02_2017.